Literature DB >> 12605072

Alcoholism: allostasis and beyond.

George F Koob1.   

Abstract

Alcoholism is a chronic relapsing disorder characterized by compulsive drinking, loss of control over intake, and impaired social and occupational function. Animal models have been developed for various stages of the alcohol addiction cycle with a focus on the motivational effects of withdrawal, craving, and protracted abstinence. A conceptual framework focused on allostatic changes in reward function that lead to excessive drinking provides a heuristic framework with which to identify the neurobiologic mechanisms involved in the development of alcoholism. Neuropharmacologic studies in animal models have provided evidence for specific neurochemical mechanisms in specific brain reward and stress circuits that become dysregulated during the development of alcohol dependence. The brain reward system implicated in the development of alcoholism comprises key elements of a basal forebrain macrostructure termed the extended amygdala that includes the central nucleus of the amygdala, the bed nucleus of the stria terminalis, and a transition zone in the medial (shell) part of the nucleus accumbens. There are multiple neurotransmitter systems that converge on the extended amygdala that become dysregulated during the development of alcohol dependence, including gamma-aminobutyric acid, opioid peptides, glutamate, serotonin, and dopamine. In addition, the brain stress systems may contribute significantly to the allostatic state. During the development of alcohol dependence, corticotropin-releasing factor may be recruited, and the neuropeptide Y brain antistress system may be compromised. These changes in the reward and stress systems are hypothesized to maintain hedonic stability in an allostatic state, as opposed to a homeostatic state, and as such convey the vulnerability for relapse in recovering alcoholics. The allostatic model not only integrates molecular, cellular, and circuitry neuroadaptations in brain motivational systems produced by chronic alcohol ingestion with genetic vulnerability but also provides a key to translate advances in animal studies to the human condition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605072     DOI: 10.1097/01.ALC.0000057122.36127.C2

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  315 in total

1.  Ethanol-induced activation of AKT and DARPP-32 in the mouse striatum mediated by opioid receptors.

Authors:  Karl Björk; Anton Terasmaa; Hui Sun; Annika Thorsell; Wolfgang H Sommer; Markus Heilig
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist.

Authors:  George R Breese; Darin J Knapp; David H Overstreet
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

Review 3.  The neurobiology of binge-like ethanol drinking: evidence from rodent models.

Authors:  Gretchen M Sprow; Todd E Thiele
Journal:  Physiol Behav       Date:  2012-01-08

Review 4.  Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury.

Authors:  Mark A Prendergast; Patrick J Mulholland
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

5.  TLR4-MyD88 signalling: a molecular target for alcohol actions.

Authors:  Subhash C Pandey
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  Greater elevation in risk for nicotine dependence per pack of cigarettes smoked among those with an anxiety disorder.

Authors:  Matt G Kushner; Kyle R Menary; Eric W Maurer; Paul Thuras
Journal:  J Stud Alcohol Drugs       Date:  2012-11       Impact factor: 2.582

7.  The role of matrix metalloproteinase-9 in negative reinforcement learning and plasticity in alcohol dependence.

Authors:  Bok Soon Go; Sunil Sirohi; Brendan M Walker
Journal:  Addict Biol       Date:  2019-01-16       Impact factor: 4.280

8.  Medial prefrontal cortex neuropeptide Y modulates binge-like ethanol consumption in C57BL/6J mice.

Authors:  Stacey L Robinson; Isabel M Marrero; Carlos A Perez-Heydrich; Marian T Sepulveda-Orengo; Kathryn J Reissner; Todd E Thiele
Journal:  Neuropsychopharmacology       Date:  2019-01-07       Impact factor: 7.853

9.  GDNF and alcohol use disorder.

Authors:  Segev Barak; Somayeh Ahmadiantehrani; Marian L Logrip; Dorit Ron
Journal:  Addict Biol       Date:  2018-05-04       Impact factor: 4.280

10.  Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours.

Authors:  Amul J Sakharkar; Huaibo Zhang; Lei Tang; Kathryn Baxstrom; Guangbin Shi; Sachin Moonat; Subhash C Pandey
Journal:  Int J Neuropsychopharmacol       Date:  2014-02-17       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.